ZEMDRI

Peak

plazomicin

NDAINTRAVENOUSSOLUTIONPriority Review

Approved

Jun 2018

Lifecycle

Peak

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Jun 25, 2032

76 months away

Patent Expiry

Jun 25, 2032

Exclusivity Expiry

Jun 25, 2028

Patent Records (4)

Patent #	Expiry	Type	Use Code
8822424	Nov 21, 2028	Product	—
9266919	Nov 21, 2028		U-2328
9688711	Nov 21, 2028	Substance	U-2328
8383596	Jun 25, 2032	Substance	U-2328

Company

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers